Literature DB >> 30310690

Insights from the European Respiratory Society 2018 Annual International Congress in the fields of thoracic surgery and lung transplantation.

Rogier A S Hoek1, Stelios Gaitanakis2, Merel E Hellemons1.   

Abstract

Year:  2018        PMID: 30310690      PMCID: PMC6174134          DOI: 10.21037/jtd.2018.09.08

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  22 in total

1.  Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation.

Authors:  Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill
Journal:  J Heart Lung Transplant       Date:  2005-06-04       Impact factor: 10.247

2.  Quantitative Computed Tomography Metrics From the Transplanted Lung can Predict Forced Expiratory Volume in the First Second After Lung Transplantation.

Authors:  Eduardo J Mortani Barbosa; Haochang Shou; Scott Simpsom; James Gee; Nicholas Tustison; James C Lee
Journal:  J Thorac Imaging       Date:  2018-03       Impact factor: 3.000

3.  Efficacy and Cost of Awake Thoracoscopy and Video-Assisted Thoracoscopic Surgery in the Undiagnosed Pleural Effusion.

Authors:  Christine M McDonald; Camille Pierre; Marc de Perrot; Gail Darling; Marcelo Cypel; Andrew Pierre; Thomas Waddell; Shaf Keshavjee; Kazuhiro Yasufuku; Kasia Czarnecka-Kujawa
Journal:  Ann Thorac Surg       Date:  2018-03-22       Impact factor: 4.330

4.  Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1.

Authors:  Seung-Myoung Son; Hye-Suk Han; Jin Young An; Kang Hyeon Choe; Ki Man Lee; Ki Hyeong Lee; So-Seul Kim; Yong-Moon Lee; Ho-Chang Lee; Hyung Geun Song; Ok-Jun Lee
Journal:  Pathology       Date:  2015-02       Impact factor: 5.306

5.  Reestablishment of recipient-associated microbiota in the lung allograft is linked to reduced risk of bronchiolitis obliterans syndrome.

Authors:  Dana L Willner; Philip Hugenholtz; Stephanie T Yerkovich; Maxine E Tan; Joshua N Daly; Nancy Lachner; Peter M Hopkins; Daniel C Chambers
Journal:  Am J Respir Crit Care Med       Date:  2013-01-17       Impact factor: 21.405

6.  Awake thoracoscopic biopsy of interstitial lung disease.

Authors:  Eugenio Pompeo; Paola Rogliani; Benedetto Cristino; Orazio Schillaci; Giuseppe Novelli; Cesare Saltini
Journal:  Ann Thorac Surg       Date:  2012-12-13       Impact factor: 4.330

Review 7.  A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.

Authors:  B M Vanaudenaerde; I Meyts; R Vos; N Geudens; W De Wever; E K Verbeken; D E Van Raemdonck; L J Dupont; G M Verleden
Journal:  Eur Respir J       Date:  2008-10       Impact factor: 16.671

8.  Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients.

Authors:  C Hsu
Journal:  Diagn Cytopathol       Date:  1987-03       Impact factor: 1.582

9.  Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.

Authors:  Vincent G Valentine; Meera R Gupta; James E Walker; Leonardo Seoane; Ryan W Bonvillain; Gisele A Lombard; David Weill; Gundeep S Dhillon
Journal:  J Heart Lung Transplant       Date:  2009-02       Impact factor: 10.247

10.  The value of multiple preparations in the diagnosis of malignant pleural effusions. A cost-benefit analysis.

Authors:  R L Starr; M E Sherman
Journal:  Acta Cytol       Date:  1991 Sep-Oct       Impact factor: 2.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.